Acadia Healthcare (ACHC) Set to Announce Quarterly Earnings on Wednesday

Acadia Healthcare (NASDAQ:ACHC) is set to announce its earnings results after the market closes on Wednesday, May 1st. Analysts expect the company to announce earnings of $0.80 per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Wednesday, February 28th. The company reported $0.85 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.80 by $0.05. The firm had revenue of $742.80 million during the quarter, compared to analyst estimates of $727.60 million. Acadia Healthcare had a negative net margin of 0.74% and a positive return on equity of 11.21%. The business’s revenue was up 10.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.70 earnings per share. On average, analysts expect Acadia Healthcare to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Acadia Healthcare Stock Up 0.3 %

Shares of ACHC opened at $73.59 on Monday. The firm has a market capitalization of $6.80 billion, a P/E ratio of -294.36, a P/E/G ratio of 2.17 and a beta of 1.31. Acadia Healthcare has a 12-month low of $66.49 and a 12-month high of $87.77. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 0.48. The firm has a fifty day moving average price of $78.07 and a 200-day moving average price of $77.74.

Insider Activity

In other news, Director Wade D. Miquelon sold 2,203 shares of the company’s stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total transaction of $188,114.17. Following the transaction, the director now owns 46,074 shares in the company, valued at $3,934,258.86. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 2.80% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on ACHC shares. Stephens raised shares of Acadia Healthcare from an “equal weight” rating to an “overweight” rating and set a $92.00 price objective for the company in a research note on Friday, January 5th. Mizuho upped their price objective on shares of Acadia Healthcare from $77.00 to $84.00 and gave the stock a “neutral” rating in a research note on Wednesday, March 6th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $90.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, March 5th. Royal Bank of Canada reiterated an “outperform” rating and issued a $94.00 target price on shares of Acadia Healthcare in a report on Monday, March 4th. Finally, Barclays assumed coverage on shares of Acadia Healthcare in a report on Wednesday, March 6th. They issued an “overweight” rating and a $100.00 target price for the company. Four equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $92.00.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.